vs

Side-by-side financial comparison of Penumbra Inc (PEN) and UNITED FIRE GROUP INC (UFCS). Click either name above to swap in a different company.

Penumbra Inc is the larger business by last-quarter revenue ($385.4M vs $365.8M, roughly 1.1× UNITED FIRE GROUP INC). On growth, Penumbra Inc posted the faster year-over-year revenue change (22.1% vs 9.8%). Over the past eight quarters, Penumbra Inc's revenue compounded faster (17.6% CAGR vs 11.2%).

Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm.

The United Fruit Company was an American multinational corporation that traded in tropical fruit grown on Latin American plantations and sold in the United States and Europe. The company was formed in 1899 from the merger of the Boston Fruit Company with Minor C. Keith's banana-trading enterprises. It flourished in the early and mid-20th century, and it came to control vast territories and transportation networks in Central America, the Caribbean coast of Colombia, and the West Indies. Althou...

PEN vs UFCS — Head-to-Head

Bigger by revenue
PEN
PEN
1.1× larger
PEN
$385.4M
$365.8M
UFCS
Growing faster (revenue YoY)
PEN
PEN
+12.3% gap
PEN
22.1%
9.8%
UFCS
Faster 2-yr revenue CAGR
PEN
PEN
Annualised
PEN
17.6%
11.2%
UFCS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PEN
PEN
UFCS
UFCS
Revenue
$385.4M
$365.8M
Net Profit
$47.3M
Gross Margin
68.0%
Operating Margin
15.4%
13.2%
Net Margin
12.3%
Revenue YoY
22.1%
9.8%
Net Profit YoY
40.6%
EPS (diluted)
$1.20
$1.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PEN
PEN
UFCS
UFCS
Q4 25
$385.4M
$365.8M
Q3 25
$354.7M
$354.0M
Q2 25
$339.5M
$335.5M
Q1 25
$324.1M
$331.1M
Q4 24
$315.5M
$333.2M
Q3 24
$301.0M
$323.0M
Q2 24
$299.4M
$301.2M
Q1 24
$278.7M
$296.0M
Net Profit
PEN
PEN
UFCS
UFCS
Q4 25
$47.3M
Q3 25
$45.9M
$39.2M
Q2 25
$45.3M
$22.9M
Q1 25
$39.2M
$17.7M
Q4 24
$33.7M
Q3 24
$29.5M
$19.7M
Q2 24
$-60.2M
$-2.7M
Q1 24
$11.0M
$13.5M
Gross Margin
PEN
PEN
UFCS
UFCS
Q4 25
68.0%
Q3 25
67.8%
Q2 25
66.0%
Q1 25
66.6%
Q4 24
66.8%
Q3 24
66.5%
Q2 24
54.4%
Q1 24
65.0%
Operating Margin
PEN
PEN
UFCS
UFCS
Q4 25
15.4%
13.2%
Q3 25
13.8%
13.7%
Q2 25
12.0%
8.7%
Q1 25
12.4%
6.6%
Q4 24
13.6%
11.9%
Q3 24
11.7%
7.7%
Q2 24
-27.0%
-1.3%
Q1 24
4.3%
5.5%
Net Margin
PEN
PEN
UFCS
UFCS
Q4 25
12.3%
Q3 25
12.9%
11.1%
Q2 25
13.3%
6.8%
Q1 25
12.1%
5.3%
Q4 24
10.7%
Q3 24
9.8%
6.1%
Q2 24
-20.1%
-0.9%
Q1 24
3.9%
4.6%
EPS (diluted)
PEN
PEN
UFCS
UFCS
Q4 25
$1.20
$1.45
Q3 25
$1.17
$1.49
Q2 25
$1.15
$0.87
Q1 25
$1.00
$0.67
Q4 24
$0.88
$1.22
Q3 24
$0.75
$0.76
Q2 24
$-1.55
$-0.11
Q1 24
$0.28
$0.52

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PEN
PEN
UFCS
UFCS
Cash + ST InvestmentsLiquidity on hand
$186.9M
$156.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.4B
$941.2M
Total Assets
$1.8B
$3.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PEN
PEN
UFCS
UFCS
Q4 25
$186.9M
$156.3M
Q3 25
$321.0M
$233.7M
Q2 25
$421.8M
$202.1M
Q1 25
$376.1M
$183.7M
Q4 24
$324.4M
$200.9M
Q3 24
$280.5M
$197.4M
Q2 24
$288.3M
$153.4M
Q1 24
$223.1M
$217.8M
Stockholders' Equity
PEN
PEN
UFCS
UFCS
Q4 25
$1.4B
$941.2M
Q3 25
$1.4B
$898.7M
Q2 25
$1.3B
$845.7M
Q1 25
$1.2B
$817.7M
Q4 24
$1.2B
$781.5M
Q3 24
$1.1B
$785.8M
Q2 24
$1.2B
$726.6M
Q1 24
$1.2B
$736.8M
Total Assets
PEN
PEN
UFCS
UFCS
Q4 25
$1.8B
$3.8B
Q3 25
$1.7B
$3.8B
Q2 25
$1.7B
$3.7B
Q1 25
$1.6B
$3.5B
Q4 24
$1.5B
$3.5B
Q3 24
$1.5B
$3.5B
Q2 24
$1.5B
$3.4B
Q1 24
$1.6B
$3.2B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PEN
PEN
UFCS
UFCS
Operating Cash FlowLast quarter
$86.5M
$269.7M
Free Cash FlowOCF − Capex
$68.0M
FCF MarginFCF / Revenue
17.7%
Capex IntensityCapex / Revenue
4.8%
Cash ConversionOCF / Net Profit
1.83×
TTM Free Cash FlowTrailing 4 quarters
$174.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PEN
PEN
UFCS
UFCS
Q4 25
$86.5M
$269.7M
Q3 25
$58.3M
$60.8M
Q2 25
$44.9M
$53.4M
Q1 25
$49.0M
$35.7M
Q4 24
$51.1M
$340.3M
Q3 24
$56.5M
$56.5M
Q2 24
$22.6M
$91.3M
Q1 24
$38.3M
$36.2M
Free Cash Flow
PEN
PEN
UFCS
UFCS
Q4 25
$68.0M
Q3 25
$42.0M
Q2 25
$29.4M
Q1 25
$35.5M
Q4 24
$45.7M
Q3 24
$51.0M
Q2 24
$18.1M
Q1 24
$32.5M
FCF Margin
PEN
PEN
UFCS
UFCS
Q4 25
17.7%
Q3 25
11.8%
Q2 25
8.7%
Q1 25
11.0%
Q4 24
14.5%
Q3 24
16.9%
Q2 24
6.0%
Q1 24
11.7%
Capex Intensity
PEN
PEN
UFCS
UFCS
Q4 25
4.8%
Q3 25
4.6%
Q2 25
4.6%
Q1 25
4.2%
Q4 24
1.7%
Q3 24
1.8%
Q2 24
1.5%
Q1 24
2.1%
Cash Conversion
PEN
PEN
UFCS
UFCS
Q4 25
1.83×
Q3 25
1.27×
1.55×
Q2 25
0.99×
2.33×
Q1 25
1.25×
2.02×
Q4 24
1.52×
Q3 24
1.91×
2.86×
Q2 24
Q1 24
3.48×
2.68×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PEN
PEN

Thrombectomy$254.7M66%
Other$130.7M34%

UFCS
UFCS

Segment breakdown not available.

Related Comparisons